<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33244158</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Premature termination codons in SOD1 causing Amyotrophic Lateral Sclerosis are predicted to escape the nonsense-mediated mRNA decay.</ArticleTitle><Pagination><StartPage>20738</StartPage><MedlinePgn>20738</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20738</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-77716-5</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common and severe adult-onset motoneuron disease and has currently no effective therapy. Approximately 20% of familial ALS cases are caused by dominantly-inherited mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1), which represents one of the most frequent genetic cause of ALS. Despite the overwhelming majority of ALS-causing missense mutations in SOD1, a minority of premature termination codons (PTCs) have been identified. mRNA harboring PTCs are known to be rapidly degraded by nonsense-mediated mRNA decay (NMD), which limits the production of truncated proteins. The rules of NMD surveillance varying with PTC location in mRNA, we analyzed the localization of PTCs in SOD1 mRNA to evaluate whether or not those PTCs can be triggered to degradation by the NMD pathway. Our study shows that all pathogenic PTCs described in SOD1 so far can theoretically escape the NMD, resulting in the production of truncated protein. This finding supports the hypothesis that haploinsufficiency is not an underlying mechanism of SOD1 mutant-associated ALS and suggests that PTCs found in the regions that trigger NMD are not pathogenic. Such a consideration is particularly important since the availability of SOD1 antisense strategies, in view of variant treatment assignment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guissart</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHU Nimes, University of Montpellier, Nimes, France. claire.guissart@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INM, INSERM, Univ Montpellier, Montpellier, France. claire.guissart@inserm.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouzat</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHU Nimes, University of Montpellier, Nimes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INM, INSERM, Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kantar</LastName><ForeName>Jovana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHU Nimes, University of Montpellier, Nimes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INM, INSERM, Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louveau</LastName><ForeName>Baptiste</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Pharmacologie et de G&#xe9;nomique des Tumeurs Solides, H&#xf4;pital Saint Louis, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilquin</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Pharmacologie et de G&#xe9;nomique des Tumeurs Solides, H&#xf4;pital Saint Louis, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polge</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHU Nimes, University of Montpellier, Nimes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raoul</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INM, INSERM, Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lumbroso</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHU Nimes, University of Montpellier, Nimes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Neuroscience Institute of Montpellier, INM, INSERM, Univ Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018389">Codon, Nonsense</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018388">Codon, Terminator</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018389" MajorTopicYN="N">Codon, Nonsense</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018388" MajorTopicYN="N">Codon, Terminator</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059365" MajorTopicYN="N">Nonsense Mediated mRNA Decay</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33244158</ArticleId><ArticleId IdType="pmc">PMC7691510</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-77716-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-77716-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet (London, England) 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Huai J, Zhang Z. Structural properties and interaction partners of familial ALS-associated SOD1 mutants. Front. Neurol. 2019;10:527. doi: 10.3389/fneur.2019.00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00527</ArticleId><ArticleId IdType="pmc">PMC6536575</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom HR, Rumfeldt JAO, Meiering EM. Many roads lead to Rome? Multiple modes of Cu, Zn superoxide dismutase destabilization, misfolding and aggregation in amyotrophic lateral sclerosis. Essays Biochem. 2014;56:149&#x2013;165. doi: 10.1042/bse0560149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bse0560149</ArticleId><ArticleId IdType="pubmed">25131593</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, et al. SOD1 in amyotrophic lateral sclerosis: &#x2018;ambivalent&#x2019; behavior connected to the disease. Int. J. Mol. Sci. 2018;19:1345. doi: 10.3390/ijms19051345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S, Eisenberg DS. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis. Postepy Biochem. 2016;62:362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">28132491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996;13:43&#x2013;47. doi: 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RKA, Fisher EMC, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136:2342&#x2013;2358. doi: 10.1093/brain/awt097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykke-Andersen S, Jensen TH. Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat. Rev. Mol. Cell Biol. 2015;16:665&#x2013;677. doi: 10.1038/nrm4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm4063</ArticleId><ArticleId IdType="pubmed">26397022</ArticleId></ArticleIdList></Reference><Reference><Citation>Popp MW, Maquat LE. Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine. Cell. 2016;165:1319&#x2013;1322. doi: 10.1016/j.cell.2016.05.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.053</ArticleId><ArticleId IdType="pmc">PMC4924582</ArticleId><ArticleId IdType="pubmed">27259145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindeboom RGH, Vermeulen M, Lehner B, Supek F. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat. Genet. 2019;51:1645&#x2013;1651. doi: 10.1038/s41588-019-0517-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0517-5</ArticleId><ArticleId IdType="pmc">PMC6858879</ArticleId><ArticleId IdType="pubmed">31659324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L, Lee X, Song J. Mechanism for transforming cytosolic SOD1 into integral membrane proteins of organelles by ALS-causing mutations. Biochim. Biophys. Acta - Biomembr. 2015;1848:1&#x2013;7. doi: 10.1016/j.bbamem.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2014.10.002</ArticleId><ArticleId IdType="pubmed">25306968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L, Song J. SALS-linked WT-SOD1 adopts a highly similar helical conformation as FALS-causing L126Z-SOD1 in a membrane environment. Biochim. Biophys. Acta - Biomembr. 2016;1858:2223&#x2013;2230. doi: 10.1016/j.bbamem.2016.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2016.06.027</ArticleId><ArticleId IdType="pubmed">27378311</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L, et al. SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) Neuromuscul. Disord. 2006;16:800&#x2013;804. doi: 10.1016/j.nmd.2006.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2006.07.004</ArticleId><ArticleId IdType="pubmed">16952453</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddique T, Deng HX. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 1996;5:1465&#x2013;1470. doi: 10.1093/hmg/5.Supplement_1.1465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/5.Supplement_1.1465</ArticleId><ArticleId IdType="pubmed">8875253</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401&#x2013;404. doi: 10.1158/2159-8290.CD-12-0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-12-0095</ArticleId><ArticleId IdType="pmc">PMC3956037</ArticleId><ArticleId IdType="pubmed">22588877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal complementary data sources and analysis options. Sci Signal. 2014;6:1&#x2013;20.</Citation></Reference><Reference><Citation>Valdmanis PN, et al. A mutation that creates a pseudoexon in SOD1 causes familial ALS. Ann. Hum. Genet. 2009;73:652&#x2013;657. doi: 10.1111/j.1469-1809.2009.00546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-1809.2009.00546.x</ArticleId><ArticleId IdType="pubmed">19847927</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T, et al. A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants. Ann. Neurol. 2012;72:739&#x2013;749. doi: 10.1002/ana.23668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23668</ArticleId><ArticleId IdType="pubmed">23280792</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. A new function of copper zinc superoxide dismutase: as a regulatory DNA-binding protein in gene expression in response to intracellular hydrogen peroxide. Nucl. Acids Res. 2019;47:5074&#x2013;5085. doi: 10.1093/nar/gkz256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz256</ArticleId><ArticleId IdType="pmc">PMC6547762</ArticleId><ArticleId IdType="pubmed">31162603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Hernandez M, et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat. Med. 2020;26:118&#x2013;130. doi: 10.1038/s41591-019-0674-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0674-1</ArticleId><ArticleId IdType="pubmed">31873312</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Brown RH. Silencing strategies for therapy of SOD1-mediated ALS. Neurosci. Lett. 2017;636:32&#x2013;39. doi: 10.1016/j.neulet.2016.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.07.059</ArticleId><ArticleId IdType="pubmed">27507699</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoul C, et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat. Med. 2005;11:423&#x2013;428. doi: 10.1038/nm1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1207</ArticleId><ArticleId IdType="pubmed">15768028</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J. Clin. Investig. 2018;128:3558&#x2013;3567. doi: 10.1172/JCI99081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99081</ArticleId><ArticleId IdType="pmc">PMC6063493</ArticleId><ArticleId IdType="pubmed">30010620</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12:435&#x2013;442. doi: 10.1016/S1474-4422(13)70061-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70061-9</ArticleId><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W, et al. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 2018;26:1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, et al. Phenotype in an infant with SOD1 homozygous truncating mutation. N. Engl. J. Med. 2019;381:486&#x2013;488. doi: 10.1056/NEJMc1905039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1905039</ArticleId><ArticleId IdType="pubmed">31314961</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, et al. SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 2019;142:2230&#x2013;2237. doi: 10.1093/brain/awz182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz182</ArticleId><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="pubmed">31332433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science (80-.) 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw MP, et al. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathol. Commun. 2018;6:125. doi: 10.1186/s40478-018-0629-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0629-7</ArticleId><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters R, Manion J, Neely GG. Dissecting motor neuron disease with Drosophila melanogaster. Front. Neurosci. 2019;13:331. doi: 10.3389/fnins.2019.00331.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00331</ArticleId><ArticleId IdType="pmc">PMC6473072</ArticleId><ArticleId IdType="pubmed">31031583</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenson PD, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum. Genet. 2017;136:665&#x2013;677. doi: 10.1007/s00439-017-1779-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1779-6</ArticleId><ArticleId IdType="pmc">PMC5429360</ArticleId><ArticleId IdType="pubmed">28349240</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JT, et al. Integrative genome viewer. Nat. Biotechnol. 2011;29:24&#x2013;26. doi: 10.1038/nbt.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1754</ArticleId><ArticleId IdType="pmc">PMC3346182</ArticleId><ArticleId IdType="pubmed">21221095</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2003;4:62&#x2013;73. doi: 10.1080/14660820310011700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310011700</ArticleId><ArticleId IdType="pubmed">14506936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Shen E, Shi D, Sun Z, Cai T. Identification of a novel Cys146X mutation of SOD1 in familial amyotrophic lateral sclerosis by whole-exome sequencing. Genet. Med. 2012;14:823&#x2013;826. doi: 10.1038/gim.2012.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2012.50</ArticleId><ArticleId IdType="pubmed">22595939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, et al. A novel SOD1 mutation in amyotrophic lateral sclerosis with a distinct clinical phenotype. Amyotroph. Lateral Scler. 2012;13:149&#x2013;154. doi: 10.3109/17482968.2011.621437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.621437</ArticleId><ArticleId IdType="pubmed">22185396</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Li L, Chen K, Liu X. Identification of the mutation of SOD1 gene in a familial amyotrophic lateral sclerosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21:149&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">15079798</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K, et al. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2017;53(195):e1&#x2013;195.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28222900</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, et al. A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms. Neurobiol. Aging. 2018;72(189):e11&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236613</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M, et al. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann. Neurol. 1997;42:803&#x2013;807. doi: 10.1002/ana.410420518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420518</ArticleId><ArticleId IdType="pubmed">9392581</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A, et al. A two basepair deletion in the SOD 1 gene causes familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 1994;3:2061&#x2013;2062.</Citation><ArticleIdList><ArticleId IdType="pubmed">7874127</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, et al. Absence of the mutant SOD1 in familial amyotrophic lateral sclerosis (FALS) with two base pair deletion in the SOD1 gene. Acta Neurol. Scand. 1997;95:167&#x2013;172. doi: 10.1111/j.1600-0404.1997.tb00090.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1997.tb00090.x</ArticleId><ArticleId IdType="pubmed">9088386</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Hart PJ, Borchelt DR, Andersen PM. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum. Mol. Genet. 2009;18:3217&#x2013;3226. doi: 10.1093/hmg/ddp260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp260</ArticleId><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain. 1997;120:1723&#x2013;1737. doi: 10.1093/brain/120.10.1723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/120.10.1723</ArticleId><ArticleId IdType="pubmed">9365366</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127:73&#x2013;88. doi: 10.1093/brain/awh005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrell RW, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology. 1997;48:746&#x2013;751. doi: 10.1212/WNL.48.3.746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.3.746</ArticleId><ArticleId IdType="pubmed">9065559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, et al. A novel 10-base pair insertion mutation in exon 5 of the SOD1 gene in a Chinese family with amyotrophic lateral sclerosis. Neurobiol. Aging. 2016;45(212):e1&#x2013;212.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27297615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata C, Morita M, Shibata N, Nakano I. Familial amyotrophic lateral sclerosis (FALS) with a novel SOD1 gene mutation: a clinicopathological study. Rinsho Shinkeigaku. 2007;47:211&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">17585602</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JA, et al. SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience. Amyotroph. Lateral Scler. 2012;13:217&#x2013;222. doi: 10.3109/17482968.2011.643899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.643899</ArticleId><ArticleId IdType="pubmed">22292843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandi M, et al. Next-generation characterization of the cancer cell line encyclopedia. Nature. 2019;569:503&#x2013;508. doi: 10.1038/s41586-019-1186-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1186-3</ArticleId><ArticleId IdType="pmc">PMC6697103</ArticleId><ArticleId IdType="pubmed">31068700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>